Podcast Episodes
Back to Search
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
Season 1
Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in …
2 years, 3 months ago
Key Presentations on Lymphoma from Recent Major Conferences
Season 1
Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatme…
2 years, 3 months ago
Bispecific Antibodies in the Management of Multiple Myeloma
Season 1
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bisp…
2 years, 4 months ago
Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Season 1
Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphi…
2 years, 4 months ago
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
Season 1
Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-pos…
2 years, 4 months ago
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
Season 1
Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progr…
2 years, 4 months ago
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
Season 1
Drs Rita Nanda, Sara M Tolaney, Julia Foldi, Laura Huppert and Saba Shaikh discuss available and emerging research, patient cases from parti…
2 years, 4 months ago
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
Season 1
Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-…
2 years, 4 months ago
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Season 1
Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategi…
2 years, 4 months ago
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
Season 1
Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and n…
2 years, 4 months ago